Meanwhile, HMGA1 expression was increased in molecular phenotypes with poor prognosis (ER-, PR-, and HER2+) and associated with high-grade group, lymph node metastasis, and NPI (Nottingham Prognostic Index). This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.